Botulinum toxin A treatment for gastrocnemius tightness and chronic plantar fasciitis
Official title: Botulinum Toxin Injection As Treatment for Proximal Medial Gastrocnemius Muscle Tightness with Subsequent Chronic Plantar Fasciitis - a Prospective Clinical Cohort Study
Run by Oslo University Hospital · NCT05218785 · Data updated 2026-11-12
This study is testing if botulinum toxin A injections can help people with tight calf muscles and chronic plantar fasciitis feel better compared to standard surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 1 site (Oslo, Oslo) |
| Status | Recruiting |
| Started | January 13, 2022 |
| Main results expected | January 2026 |
| Study ends | January 2026 |
| Registry record updated | March 30, 2025 |
| Trial ID | NCT05218785 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-75 with isolated gastrocnemius contracture and chronic plantar fasciitis who have not responded to at least three months of physical therapy.
✕Probably not a fit
Patients who have previously undergone surgery for plantar fasciitis or have severe foot and ankle malalignment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective clinical cohort study will follow 40 patients receiving botulinum toxin A injections for proximal medial gastrocnemius tightness, which is linked to chronic plantar fasciitis. Participants will receive three injections of 75IU at three-month intervals and will be monitored over two years using Patient Related Outcome Measures (PROMS) and physical tests. The study aims to evaluate the effectiveness of this treatment approach compared to traditional surgical methods. The main outcome measure will be the Manchester Oxford Foot Questionnaire (MOxFQ).
Why it matters
Potential benefit: If successful, this treatment could provide significant relief for patients suffering from chronic plantar fasciitis linked to gastrocnemius tightness.
How similar studies have gone: While traditional surgical methods have been well-studied, the use of botulinum toxin A for this specific condition is relatively novel and has shown promising results in preliminary studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: 1. Age 18-75 years. 2. An isolated gastrocnemius contracture must be verified with the Silfverskiölds test before inclusion. 3. Diagnosis plantar fasciitis verified clinically by an orthopaedic surgeon. 4. Diagnosis verified by MRI. MRI criteria: Thickening of the plantar fascia, oedema in the calcaneus, pathological signal changes in the plantar fascia (35) 5. Duration of symptoms must be at least 12 months prior to first BTA injection. 6. Conventional Physical Therapy must have been tried at least three months without a significant reduction of symptoms in the affected foot. Exclusion criteria: 1. Previously undergone surgery for plantar fasciitis. 2. Patients with severe talocrural pathology or serious malalignment of foot and ankle 3. Severely reduced peripheral circulation 4. History of alcoholism, drug abuse, psychological or other emotional problems likely to jeopardize informed consent. 5. Patients with a contraindication/non-compliance for MRI examination. 6. History of allergic reaction/anaphylactic reaction or other contraindication to botulinum toxin. 7. Not able to read and/or speak a Scandinavian language or English adequately.
Where it's running
-
Oslo University Hospital, Orthopedic Department Ullevål
Oslo, Oslo, Norway Recruiting
Study contacts
- Study coordinator: Elisabet Ellingsen Husebye, MD PhD
- Email: uxngng@ous-hf.no
- Phone: +47 91 50 27 70
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
F-18 PET/CT-Guided Lu-177 Therapy Added to Corticosteroid Injections for Chronic Plantar Fasciitis
This study tests whether adding a low-dose Lu-177 therapy guided by F-18 NaF PET/CT to standard corticosteroid injections helps relieve pain and improve function in adults with chronic plantar fasciitis who didn’t improve with conservative care.
-
Video-guided vs physician-led exercise training for plantar fasciitis
This trial tests whether a standardized video-based exercise program works as well as in-person instruction by a physician for adults with plantar fasciitis.
-
Deep transverse friction massage versus instrument-assisted soft tissue mobilization for pregnancy-related plantar fasciitis
This test compares deep transverse friction massage and instrument-assisted soft tissue mobilization to see which better reduces heel pain and improves walking for pregnant women with plantar fasciitis.
-
Dissolvable SakuraBead embolization for plantar fascia pain
This trial will try dissolvable SakuraBead embolization in adults with plantar fasciitis to see if it reduces heel pain better than shockwave therapy.
-
Effects of dry needling combined with physical therapy on plantar fasciitis
This study is testing if combining dry needling with regular physical therapy can help people aged 40-60 with chronic heel pain feel better and move more easily compared to just doing physical therapy alone.
-
Comparing IASTM and Kinesiotaping for Plantar Fasciitis
This study is testing whether a hands-on treatment called IASTM or a supportive taping method works better to help people aged 20-40 with chronic heel pain from plantar fasciitis feel better and improve their foot function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.